SS
Salim Syed Mizuho Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
7
Avg Return
Past Year
Past Year
31%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
85.7%
Neutral
14.3%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Upgraded
| $121 |
13%
upside
| 1 | +4.2% |
0
%
| 8 Dec ‘25 1 month ago |
|
|
|
Outperform
Maintained
| $40 |
26%
upside
| 1 | -16% |
0
%
| 20 Nov ‘25 1 month ago |
|
|
|
Outperform
Maintained
| $14 |
570%
upside
| 1 | +12% |
0
%
| 10 Jun ‘25 7 months ago |
|
|
|
Outperform
Maintained
| $84 |
34%
upside
| 1 | +106% |
0
%
| 29 May ‘25 7 months ago |
|
|
|
Outperform
Maintained
| $169 |
10%
downside
| 1 | +61% |
0
%
| 7 May ‘25 8 months ago |
|
|
|
Neutral
Maintained
| $280 |
14%
downside
| 1 | – |
–
| 7 May ‘25 8 months ago |
|
|
|
Outperform
Maintained
| $117 |
3%
downside
| 1 | +17% |
0
%
| 5 May ‘25 8 months ago |
|